Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Boehringer Ingelheim has begun offering outside scientists free access to select preclinical molecules for nonclinical investigation on an online platform called opnME.com. Most molecules are offered without intellectual property agreements. Boehringer is also offering a crowdsourcing service on the site through which scientists submit proposals for projects that can be developed with the company’s researchers. The platform follows other moves at the firm to promote collaboration, including Research Beyond Borders, a research partnership initiative, and the Boehringer Ingelheim Venture Fund.
This article has been sent to the following recipient: